Health Invest Partners Ab has filed its 13F form on November 12, 2024 for Q3 2024 where it was disclosed a total value porftolio of $206 Million distributed in 36 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Eli Lilly & CO with a value of $27.1M, Unitedhealth Group Inc with a value of $20.8M, Merck & Co., Inc. with a value of $17.6M, Thermo Fisher Scientific Inc. with a value of $13.6M, and Amgen Inc with a value of $9.33M.
Examining the 13F form we can see an increase of $46.6M in the current position value, from $160M to 206M.
Below you can find more details about Health Invest Partners Ab portfolio as well as his latest detailed transactions.